Contribute to the development of drug substance manufacturing processes by leading partnerships with CDMOs and ensuring compliance with regulatory guidelines.
COMPANY BACKGROUND
Akero Therapeutics, a Novo Nordisk company, is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases marked by high unmet need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with MASH(metabolic dysfunction-associated steatohepatitis).
We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.
Job Summary
The experienced professional is responsible for drug substance process development and manufacturing support in the Technical Operation division. Key responsibilities include oversite and technical guidance for upstream and downstream process development activities executed at CDMOs for next generation processes, technology transfer, development studies to enable process validation, and process support and trending analysis for clinical and commercial supply chain activities. The Associate Director will be a key member within the Technical Operations team and is expected to partner with functional areas such as Analytical Development, Drug Product, Quality Assurance, Regulatory CMC and Quality Control. The Associate Director will report to the VP, Drug Substance.
The ideal candidate will have prior experience leading late-stage drug substance process development efforts within a biotechnology company along with technology transfer of such processes to manufacturing and execution of required studies to enable Process Performance Qualification (PPQ). The candidate should also have experience executing, authoring and reviewing key process development and process characterization studies and CMC regulatory sections for health authorities, and have a strong understanding of biologics drug substance manufacturing, regulatory expectations and guidance. Knowledge of statistical methods utilized for process development and manufacturing process control is also important. Liquid formulation experience is also a plus. The individual in this role will be an important contributor to the development of late-stage drug substance manufacturing processes, collaborating within the Drug Substance team, peers in AD/QC/QC/DP/PM, and partners at CDMO and other contracted support teams.
Relationships:
Reporting to the VP, Drug Substance.
The position will interact with all areas of CMC. In addition, clinical within Novo Nordisk. The position interacts with team members at the IC through Vice President level. The position requires experience interacting with senior level positions in each of these departments and a good understanding of how these peer teams operate, ideally through experience working within these teams (broad experience).
Externally, the position will engage with CDMOs.
Job Responsibilities
Physical Requirement: Ability to travel up to 20%. Internationally and Domestic
Qualifications
The base compensation range for this position is $152,700 to $267,300. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance.
Akero Therapeutics, a Novo Nordisk company, offers long-term incentive compensation depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.
The job posting is anticipated to close on March 16th. The Company may however extend this time-period, in which case the posting will remain available on our careers website at https://akerotx.com/job-opportunities.
EEO Statement:
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
Akero Therapeutics is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative treatments for patients suffering from serious metabolic diseases. With a focus on high unmet medical needs, we specialize in creating transformative therapies that can significantly improve patient outcomes.
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Associate Director Q&A's